Onglyza Heart Failure Injuries Lawsuits Centralized. Recently, the U.S. Judicial Panel on Multidistrict Litigation (JPML) has ordered that all filed federal Onglyza heart failure injuries lawsuits be consolidated and centralized as part of multidistrict litigation or MDL. Type 2 diabetic patients who used Onglyza and developed heart problems allegedly caused by…
Onglyza Heart Failure. Wrendell Chester, from Texas, recently filed a personal injury and product liability lawsuit, against Bristol-Myers Squibb and AstraZeneca, the manufacturers of the drug. Chester claims that the companies failed to adequately warn patients and doctors about the risk of heart failure from side effects of Onglyza and…
In the federal court system, a Multidistrict Litigation (MDL) has been established to centralize Byetta, Januvia, Janumet and Victoza pancreatic cancer lawsuits filed in U.S. District Courts by the users of these diabetic drugs. There are currently at least 262 cases consolidated as part of an MDL, before U.S. District…
The National Institutes of Health held a workshop, addressing the risks associated with the newer diabetic drugs. These medications, known as Incretic Mimetics are coming under fire for alleged increased risk of pancreatic cancer. Merck & Co., Novo Nordisk A/S and others, the manufacturers of these drugs may be asked…